Fruquintinib Enhances the Antitumor Immune Responses of Anti-Programmed Death Receptor-1 in Colorectal Cancer

Li, QL; Cheng, XJ; Zhou, C; Tang, Y; Li, FL; Zhang, BW; Huang, TL; Wang, JZ; Tu, SP

Tu, SP (通讯作者)，Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R China.;Wang, JZ (通讯作者)，Zhengzhou Univ, Affiliated Canc Hosp, Henan Canc Hosp, Dept Oncol, Zhengzhou, Peoples R China.

FRONTIERS IN ONCOLOGY, 2022; 12 ():

Abstract

BackgroundProgrammed death receptor-1 (PD-1) blockade shows little benefit in patients with microsatellite-stable colorectal cancer (MSS-CRC). Fruquin......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索